MINDCURE Joins Digital Therapeutics Alliance to Drive Innovation in the Mental...

Awakn Life Sciences Reports Second Quarter 2021 Financial Results and Business...

Nova Mentis Applies to US FDA for Psilocybin Orphan Drug Designation...

Understanding ‘Spiritual Emergency’ in the Context of Psychedelics

atai Life Sciences Increases Loan in Principal by US$6m to Support...

Small Pharma Announces Engagement of Investor Relations Provider

Fear of Death Impacts Quality of Life-How Psychedelics Can Help

PT262 – Carlene MacMillan, M.D. – Set, Setting, and Systems: Adding...

Perception Neuroscience initiates Phase 2a study of PCN-101 (R-ketamine) for treatment...

Mindset Pharma Further Validates Lead Candidate, MSP-1014, as a Next Generation...

Load more